IL6 and COVID-19: Even though the pathophysiology of COVID-19 has not yet been fully understood, critically ill patients have high levels of cytokines, particularly interleukin-6 (IL-6), suggesting that hyperinflammation may contribute to morbidity and mortality in this disease [7,9].